Koninklijke Philips N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
08 sep 2008 - 07:58
Statutaire naam
Koninklijke Philips N.V.
Titel
Philips further expands healthcare business in emerging markets by acquiring India-based Alpha X-Ray Technologies
Bericht
Amsterdam, the Netherlands and Mumbai, India – Royal Philips Electronics (NYSE: PHG, AEX: PHI) today announced it has reached an agreement to acquire India-based Alpha X-Ray Technologies. Alpha is a leading manufacturer of Cardiovascular X-Ray systems targeting the economy segment of the Indian market. Upon closing of this transaction in the fourth quarter of 2008, which is subject to certain contractual and other conditions such as regulatory approvals, Alpha will become part of the Cardiovascular X-Ray business within Philips’ Healthcare sector. Financial details of this agreement were not disclosed.
Today’s announcement marks Philips’ strong presence in high-growth healthcare market in emerging economies, and follows the earlier acquisitions of healthcare companies Brazilian Dixtal Biomédica e Tecnologia, Shenzhen Goldway Industrial in China and VMI Sistemas Medicos in Brazil. In commenting on the deal, Mr. Ronald de Jong, CEO Emerging Markets of Philips Healthcare, said: “The acquisition of Alpha is another great example of how Philips continues to strengthen its industrial and commercial footprint in emerging markets. It provides us with significant presence in the high-growth economy segment for Cardiovascular X-Ray systems, underlining our commitment to deliver affordable healthcare solutions in emerging markets.”
Alpha’s high-quality and clinically proven economy segment product portfolio complements Philips’ existing high-end Cardiovascular X-Ray range and helps Philips to capture an even larger slice of the global EUR 1.8 billion Cardiovascular X-Ray market. Analysts estimate that the economy segment is the fastest growing segment of the global Cardiovascular X-Ray market, with anticipated annual growth rates of 10% to 15% in coming years. Philips will leverage its global distribution network to sell Alpha’s Cardiovascular X-Ray products thus maximizing the value of the acquisition and adding another growth engine to Philips Healthcare’s emerging market
Gerelateerde downloads
Datum laatste update: 01 september 2024